HVC
ARIA

Healthcare Value Capital’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Healthcare Value Capital’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-100,000
Closed -$824K – 41
2015
Q1 		$824K Hold
100,000
– – 0.9% 22
2014
Q4 		$687K Hold
100,000
– – 1.26% 16
2014
Q3 		$540K Buy
+100,000
New +$584K 0.52% 24

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Healthcare Value Capital's ARIA Position: Q4 2015 in Review

Healthcare Value Capital sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2015, closing a stake of 50,000 shares — an estimated $292K sold.

Healthcare Value Capital first reported a position in ARIA in Q2 2014 and held it in 6 quarters. The position peaked at $1.24M in Q1 2015. 172 funds tracked by Wall St. Rank hold ARIA as of Q4 2015.

  • Healthcare Value Capital reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Healthcare Value Capital sold 50,000 Ariad Pharmaceuticals Inc shares in Q4 2015, an estimated $292K.
  • Healthcare Value Capital first reported a position in Ariad Pharmaceuticals Inc in Q2 2014 and held it in 6 quarters.
  • Healthcare Value Capital's Ariad Pharmaceuticals Inc position peaked at $1.24M in Q1 2015.
  • 172 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2015.

Based on Healthcare Value Capital's 13F filing for Q4 2015, filed 16 Feb 2016.